Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 433

1.

The NNPTC Turns 40 - A Look Back, a Look Ahead.

Stoner BP, Fraze J, Rietmeijer CA, Dyer J, Gandelman A, Hook EW 3rd, Johnston C, Neu NM, Rompalo AM, Bolan G; National Network of STD Clinical Prevention Training Centers*.

Sex Transm Dis. 2019 May 27. doi: 10.1097/OLQ.0000000000001018. [Epub ahead of print]

PMID:
31145270
2.

Delay in Seeking Health Care Services After Onset of Urethritis Symptoms in Men.

Aaron KJ, Van Der Pol B, Jordan SJ, Schwebke JR, Hook EW 3rd.

Sex Transm Dis. 2019 May;46(5):317-320. doi: 10.1097/OLQ.0000000000000976.

PMID:
30985634
3.

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.

Hook EW 3rd, Golden MR, Taylor SN, Henry E, Tseng C, Workowski KA, Swerdlow J, Nenninger A, Cammarata S.

Sex Transm Dis. 2019 May;46(5):279-286. doi: 10.1097/OLQ.0000000000000971.

PMID:
30985632
4.

Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study.

Hook EW 3rd, Golden MR, Taylor SN, Henry E, Tseng C, Swerdlow J, Nenninger A, Cammarata S.

Sex Transm Dis. 2019 Jan 19. doi: 10.1097/OLQ.0000000000000971. [Epub ahead of print]

PMID:
30676487
5.

Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.

Taylor SN, Marrazzo J, Batteiger BE, Hook EW 3rd, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, Mueller J.

N Engl J Med. 2018 Nov 8;379(19):1835-1845. doi: 10.1056/NEJMoa1706988.

PMID:
30403954
6.

Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae.

Scangarella-Oman NE, Hossain M, Dixon PB, Ingraham K, Min S, Tiffany CA, Perry CR, Raychaudhuri A, Dumont EF, Huang J, Hook EW 3rd, Miller LA.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01221-18. doi: 10.1128/AAC.01221-18. Print 2018 Dec.

7.

Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama.

Xiao L, Waites KB, Van Der Pol B, Aaron KJ, Hook EW 3rd, Geisler WM.

Sex Transm Dis. 2019 Jan;46(1):18-24. doi: 10.1097/OLQ.0000000000000891.

PMID:
29979336
8.

A Brief History of Evolving Diagnostics and Therapy for Gonorrhea: Lessons Learned.

Hook EW 3rd, Kirkcaldy RD.

Clin Infect Dis. 2018 Sep 28;67(8):1294-1299. doi: 10.1093/cid/ciy271.

PMID:
29659749
9.

Health Risks of American Long-Distance Truckers: Results From a Multisite Assessment.

Bachmann LH, Lichtenstein B, St Lawrence JS, Murray M, Russell GB, Hook EW 3rd.

J Occup Environ Med. 2018 Jul;60(7):e349-e355. doi: 10.1097/JOM.0000000000001319.

PMID:
29538273
10.

Is There a Continuum of Risk for Sexually Transmitted Infections Among African American Women?

Harbison HS, Austin EL, Hook EW 3rd, Muzny CA.

Sex Transm Dis. 2018 May;45(5):e20-e22. doi: 10.1097/OLQ.0000000000000750.

PMID:
29465691
11.

Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms.

Jordan SJ, Aaron KJ, Schwebke JR, Van Der Pol BJ, Hook EW 3rd.

Sex Transm Dis. 2018 Jul;45(7):e40-e42. doi: 10.1097/OLQ.0000000000000790.

PMID:
29465655
12.

Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013.

Kirkcaldy RD, Bartoces MG, Soge OO, Riedel S, Kubin G, Del Rio C, Papp JR, Hook EW 3rd, Hicks LA.

Emerg Infect Dis. 2017 Oct;23(10):1657-1663. doi: 10.3201/eid2310.170488.

13.

The Need to Promote Sexual Health in America: A New Vision for Public Health Action.

Ford JV, Ivankovich MB, Douglas JM Jr, Hook EW 3rd, Barclay L, Elders J, Satcher D, Coleman E.

Sex Transm Dis. 2017 Oct;44(10):579-585. doi: 10.1097/OLQ.0000000000000660.

PMID:
28876308
14.

Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.

Alirol E, Wi TE, Bala M, Bazzo ML, Chen XS, Deal C, Dillon JR, Kularatne R, Heim J, Hooft van Huijsduijnen R, Hook EW, Lahra MM, Lewis DA, Ndowa F, Shafer WM, Tayler L, Workowski K, Unemo M, Balasegaram M.

PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.

15.

Continued Evolution of Gonococcal Antimicrobial Resistance.

Hook EW 3rd.

Clin Infect Dis. 2017 Sep 15;65(6):924-926. doi: 10.1093/cid/cix492. No abstract available.

PMID:
28549116
16.

Population-attributable fraction of tubal factor infertility associated with chlamydia.

Gorwitz RJ, Wiesenfeld HC, Chen PL, Hammond KR, Sereday KA, Haggerty CL, Johnson RE, Papp JR, Kissin DM, Henning TC, Hook EW 3rd, Steinkampf MP, Markowitz LE, Geisler WM.

Am J Obstet Gynecol. 2017 Sep;217(3):336.e1-336.e16. doi: 10.1016/j.ajog.2017.05.026. Epub 2017 May 19.

17.

Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment.

Long JE, Wierzbicki MR, Hook EW 3rd.

Sex Transm Dis. 2017 Jun;44(6):362-364. doi: 10.1097/OLQ.0000000000000604.

18.

Meatal Swabs Contain Less Cellular Material and Are Associated with a Decrease in Gram Stain Smear Quality Compared to Urethral Swabs in Men.

Jordan SJ, Schwebke JR, Aaron KJ, Van Der Pol B, Hook EW 3rd.

J Clin Microbiol. 2017 Jul;55(7):2249-2254. doi: 10.1128/JCM.00423-17. Epub 2017 May 10.

19.

Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner Numbers.

Muzny CA, Harbison HS, Austin EL, Schwebke JR, Van Der Pol B, Hook EW 3rd.

South Med J. 2017 Mar;110(3):161-167. doi: 10.14423/SMJ.0000000000000621.

PMID:
28257539
20.

Stability Studies on Dry Swabs and Wet Mailed Swabs for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Aptima Assays.

Moncada J, Clark CB, Holden J, Hook EW 3rd, Gaydos CA, Schachter J.

J Clin Microbiol. 2017 Mar;55(3):971-977. doi: 10.1128/JCM.02235-16. Epub 2017 Jan 11.

21.

A Recommendation Against Serologic Screening for Genital Herpes Infection-What Now?

Hook EW 3rd.

JAMA. 2016 Dec 20;316(23):2493-2494. doi: 10.1001/jama.2016.17139. No abstract available.

PMID:
27997636
22.

Syphilis.

Hook EW 3rd.

Lancet. 2017 Apr 15;389(10078):1550-1557. doi: 10.1016/S0140-6736(16)32411-4. Epub 2016 Dec 18. Review. Erratum in: Lancet. 2019 Mar 9;393(10175):986.

PMID:
27993382
23.

Rate of Decline in Nontreponemal Antibody Titers and Seroreversion After Treatment of Early Syphilis.

Seña AC, Wolff M, Behets F, Martin DH, Leone P, Langley C, McNeil L, Hook EW 3rd.

Sex Transm Dis. 2017 Jan;44(1):6-10.

24.

Combined Testing for Chlamydia, Gonorrhea, and Trichomonas by Use of the BD Max CT/GC/TV Assay with Genitourinary Specimen Types.

Van Der Pol B, Williams JA, Fuller D, Taylor SN, Hook EW 3rd.

J Clin Microbiol. 2016 Dec 28;55(1):155-164. doi: 10.1128/JCM.01766-16. Print 2017 Jan.

25.

Ocular Syphilis in Context.

Hook EW 3rd.

Sex Transm Dis. 2016 Aug;43(8):528-9. doi: 10.1097/OLQ.0000000000000499. No abstract available.

PMID:
27414685
26.

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Kirkcaldy RD, Harvey A, Papp JR, Del Rio C, Soge OO, Holmes KK, Hook EW 3rd, Kubin G, Riedel S, Zenilman J, Pettus K, Sanders T, Sharpe S, Torrone E.

MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.

PMID:
27414503
27.

Reported Church Attendance at the Time of Entry into HIV Care is Associated with Viral Load Suppression at 12 Months.

Van Wagoner N, Elopre L, Westfall AO, Mugavero MJ, Turan J, Hook EW.

AIDS Behav. 2016 Aug;20(8):1706-12. doi: 10.1007/s10461-016-1347-4. English, Spanish.

28.

The Role of Early HIV Status Disclosure in Retention in HIV Care.

Elopre L, Hook EW, Westfall AO, Zinski A, Mugavero MJ, Turan J, Van Wagoner N.

AIDS Patient Care STDS. 2015 Dec;29(12):646-50. doi: 10.1089/apc.2015.0205. Epub 2015 Nov 20.

29.

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.

Kirkcaldy RD, Hook EW 3rd, Soge OO, del Rio C, Kubin G, Zenilman JM, Papp JR.

JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347. No abstract available.

30.

Chlamydia trachomatis infection in African American women who exclusively have sex with women.

Muzny CA, Kapil R, Austin EL, Brown L, Hook EW 3rd, Geisler WM.

Int J STD AIDS. 2016 Oct;27(11):978-83. doi: 10.1177/0956462415604092. Epub 2015 Sep 18.

PMID:
26384942
31.

Performance of the BD CTQx and GCQx Amplified Assays on the BD Viper LT Compared With the BD Viper XTR System.

Van Der Pol B, Hook EW 3rd, Williams JA, Smith B, Taylor SN.

Sex Transm Dis. 2015 Sep;42(9):521-3. doi: 10.1097/OLQ.0000000000000313.

PMID:
26270114
32.

Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.

Kidd S, Moore PC, Kirkcaldy RD, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Venkatasubramanian L, Ghanem KG, Hook EW 3rd.

Sex Transm Dis. 2015 Aug;42(8):434-9. doi: 10.1097/OLQ.0000000000000312.

33.

Generalized Testing for Gonococcal Antibiotic Susceptibility or Sentinel Surveillance.

Hook EW 3rd.

Sex Transm Dis. 2015 Aug;42(8):417-8. doi: 10.1097/OLQ.0000000000000321. No abstract available.

PMID:
26165431
34.

A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea.

Hook EW 3rd, Golden M, Jamieson BD, Dixon PB, Harbison HS, Lowens S, Fernandes P.

Clin Infect Dis. 2015 Oct 1;61(7):1043-8. doi: 10.1093/cid/civ478. Epub 2015 Jun 18.

PMID:
26089222
35.

Sexual Health in America: Improving Patient Care and Public Health.

Satcher D, Hook EW 3rd, Coleman E.

JAMA. 2015 Aug 25;314(8):765-6. doi: 10.1001/jama.2015.6831. No abstract available.

PMID:
26087251
36.

Evaluating the performance of the focus HerpeSelect® HSV-2 IgG in veterans with chronic hepatitis C infection.

Burton M, Van Wagoner NJ, Sunesara I, Penman A, Swiatlo E, Hook EW 3rd.

J Med Virol. 2015 Aug;87(8):1377-81. doi: 10.1002/jmv.24195. Epub 2015 Apr 23.

PMID:
25908332
37.

Predictors of HIV Disclosure in Infected Persons Presenting to Establish Care.

Elopre L, Westfall AO, Mugavero MJ, Zinski A, Burkholder G, Hook EW, Van Wagoner N.

AIDS Behav. 2016 Jan;20(1):147-54. doi: 10.1007/s10461-015-1060-8.

38.

Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.

Kirkcaldy RD, Soge O, Papp JR, Hook EW 3rd, del Rio C, Kubin G, Weinstock HS.

Antimicrob Agents Chemother. 2015 Feb;59(2):998-1003. doi: 10.1128/AAC.04337-14. Epub 2014 Dec 1.

39.

Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and men.

Muzny CA, Kapil R, Austin EL, Hook EW, Geisler WM.

Sex Health. 2014 Dec;11(6):592-3. doi: 10.1071/SH14181.

PMID:
25435197
40.

Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk.

Muzny CA, Austin EL, Harbison HS, Hook EW 3rd.

Sex Transm Dis. 2014 Oct;41(10):611-7. doi: 10.1097/OLQ.0000000000000194.

PMID:
25211257
41.

A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis C virus/herpes simplex virus type 2 coinfection.

Burton MJ, Penman A, Sunesara I, McGuire BM, Hook EW 3rd.

Am J Med Sci. 2014 Dec;348(6):455-9. doi: 10.1097/MAJ.0000000000000321.

PMID:
25163019
42.

The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.

Van Wagoner N, Geisler WM, Bachmann LH, Hook EW.

Int J STD AIDS. 2015 Jul;26(8):574-81. doi: 10.1177/0956462414546504. Epub 2014 Aug 21.

PMID:
25147236
43.

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Kirkcaldy RD, Weinstock HS, Moore PC, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Johnson S, Ghanem KG, Hook EW 3rd.

Clin Infect Dis. 2014 Oct 15;59(8):1083-91. doi: 10.1093/cid/ciu521. Epub 2014 Jul 16.

44.

HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).

Schulte JM, Bellamy AR, Hook EW 3rd, Bernstein DI, Levin MJ, Leone PA, Sokol-Anderson ML, Ewell MG, Wolff PA, Heineman TC, Belshe RB.

South Med J. 2014 Feb;107(2):79-84. doi: 10.1097/SMJ.0000000000000062.

PMID:
24926671
45.

Reply to Rapose.

Van Wagoner N, Mugavero M, Westfall A, Slater LZ, Burkholder G, Van Wagoner RH, Raper JL, Holliman J, Hook EW 3rd.

Clin Infect Dis. 2014 Jul 15;59(2):316-7. doi: 10.1093/cid/ciu263. Epub 2014 Apr 18. No abstract available.

PMID:
24748517
46.

Evolving gonococcal antimicrobial resistance: research priorities and implications for management.

Hook EW, Van Der Pol B.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv60-2. doi: 10.1136/sextrans-2013-051021. Review.

PMID:
24243882
47.

Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care.

Van Wagoner N, Mugavero M, Westfall A, Hollimon J, Slater LZ, Burkholder G, Raper JL, Hook EW 3rd.

Clin Infect Dis. 2014 Jan;58(2):295-9. doi: 10.1093/cid/cit689. Epub 2013 Nov 5.

48.

Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy.

Holman KM, Carr JA, Baddley JW, Hook EW 3rd.

Sex Transm Dis. 2013 Nov;40(11):836-8. doi: 10.1097/OLQ.0000000000000031.

PMID:
24113402
49.

Clinical evaluation of a new Pap test-based method for screening of Chlamydia trachomatis and Neisseria gonorrhoeae using liquid-based cytology media.

Martens MG, Fine P, Fuller D, Ginde SY, Hook EW 3rd, Lebed J, Mena L, Taylor SN, Van Der Pol B.

South Med J. 2013 Sep;106(9):506-12. doi: 10.1097/SMJ.0b013e3182a5f113.

PMID:
24002555
50.

Clinical management of early syphilis.

Holman KM, Hook EW 3rd.

Expert Rev Anti Infect Ther. 2013 Aug;11(8):839-43. doi: 10.1586/14787210.2013.814865. Review.

PMID:
23977939

Supplemental Content

Support Center